OUR PRODUCTS

MOBILE APPS

GENERAL INFO

IBRX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

ImmunityBio (IBRX) Earnings Date & Reports

ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

IBRX is expected to report earnings to rise 8.00% to -10 cents per share on November 07

Q3'25

Est.

$-0.11

Q2'25

Beat

by $0.01

Q1'25

Missed

by $0.02

Q4'24

Beat

by $0.08

Q3'24

Beat

by $0.04

The last earnings report on August 05 showed earnings per share of -10 cents, beating the estimate of -10 cents. With 2.56M shares outstanding, the current market capitalization sits at 2.33B.

View a ticker or compare two or three

Compare

IBRX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For IBRX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IBRX showed earnings on August 05, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a producer of cancer treatment products

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

3530 John Hopkins Court

Phone

+1 844 696-5235

Employees

628

Web

https://www.immunitybio.com